58045-41-3

Basic information

• Product Name: 4-FORMYLCINNAMIC ACID METHYL ESTER
• Synonyms: (E)-3-(4-Formylphenyl)-2-propenoic acid methyl ester;Methyl (E)-3-(4-formylphenyl)acrylate;Methyl (E)-p-formylcinnamate;(E)-4-Formylcinnamic Acid Methyl Ester;(2E)-3-(4-ForMylphenyl)-2-propenoic Acid Methyl Ester;(E)-3-(4-Formyl-phenyl)-acrylic acid methyl ester;(E)-4- mylcinnamic Acid Methyl Ester
• CAS NO: 58045-41-3
• Molecular Formula: C₁₁H₁₀O₃
• Molecular Weight: 190.2
• Product Categories: Aromatics;Miscellaneous Reagents
• Mol File: 58045-41-3.mol
• Article Data: 103

Chemical Properties

• Melting Point: 79-82 ºC
• Boiling Point: 334.1 °C at 760 mmHg
• Flash Point: 148.8 °C
• Appearance: /
• Density: 1.173
• Vapor Pressure: 0.000131mmHg at 25°C
• Refractive Index: 1.598
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Solubility: DMSO (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 4-FORMYLCINNAMIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-FORMYLCINNAMIC ACID METHYL ESTER(58045-41-3)
• EPA Substance Registry System: 4-FORMYLCINNAMIC ACID METHYL ESTER(58045-41-3)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 58045-41-3(Hazardous Substances Data)

Usage

Chemical Properties

Off-White Solid

Uses

Cinnamic Acid derivative

Synthesis Reference(s)

Synthesis, p. 747, 1984 DOI: 10.1055/s-1984-30956

InChI:InChI=1/C11H10O3/c1-14-11(13)7-6-9-2-4-10(8-12)5-3-9/h2-8H,1H3/b7-6+

Upstream product

• 1779-58-4 (methyloxycarbonylmethyl)triphenylphosphonium bromide 
• 623-27-8 terephthalaldehyde, 
• 67-56-1 methanol 
• 66885-68-5 (E)-p-formylcinnamic acid 
• 292638-85-8 acrylic acid methyl ester 
• 15164-44-0 p-(iodophenyl)carboxaldehyde 
• 87199-17-5 4-formylphenylboronic acid, 
• 104-88-1 4-chlorobenzaldehyde 
• 1122-91-4 4-bromo-benzaldehyde 
• 23359-08-2 4-formylcinnamic acid 
• 157-22-2 diazirine 
• 946-99-6 methyl 3-(4-bromomethyl)cinnamate 
• 177352-25-9 (E)-Methyl 4-(dimethoxymethyl)cinnamate 
• 78-94-4 methyl vinyl ketone 

Downstream Products

• 404951-55-9 (2E)-3-[4-[[[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenoic acid methyl ester 
• 34961-64-3 4-formyldihydrocinnamic acid 
• 1221411-79-5 methyl (2E)-3-{4-[(adamant-1-ylamino)methyl]phenyl}acrylate 
• 1352841-04-3 methyl 3-(4-(((triethylsilyl)oxy)methyl)phenyl)acrylate 
• 215258-27-8 (E)-methyl 3-(4-(dimethylcarbamoyl)phenyl)acrylate 
• 1380048-92-9 (E)-methyl 3-(4-{(R)-hydroxy[(S)-2-oxocyclopentyl]methyl}phenyl)acrylate 
• 1221411-88-6 (E)-3-(4-((((3r,5r,7r)-adamantan-1-ylmethyl)amino)methyl)-phenyl)-N-hydroxyacrylamide 

Relevant articles and documents

Palladium(II) complexes of (t-butyl salicylidene) diphenyl disulfide diamine: synthesis, structure, spectral characterization and catalytic properties

The hexadentate N2S2O2 donor ligand N,N’-bis(3,5-tert-butylsalicylidene) diphenyl disulfide-2,2’-diamine was synthesised by the condensation of 2-aminophenyl disulfide and 3,5-di-tert-butyl-2-hydroxybenzaldehyde and its mo

Removal of soluble palladium complexes from reaction mixtures by fixed-bed adsorption

The increasing use of metal-containing catalysts in producing pharmaceutical intermediates and active pharmaceutical ingredients, in conjunction with requirements of low metal content in a drug substance, has motivated the development of efficient separations processes for metals removal. In this paper, fixed-bed adsorption, an attractive alternative to batch adsorption, was investigated using a reaction mixture from a Heck coupling. Adsorption isotherm determinations using three candidate adsorbents revealed that QuadraPure TU had the greatest affinity and identified the optimal adsorption temperature. The bed residence time was key in obtaining good adsorption efficiency in subsequent fixed-bed experiments. Methods for palladium detection by HPLC were developed to monitor adsorption column performance in quasi real-time. A preliminary design methodology was developed in which actual breakthrough time is estimated from the experimentally determined tradeoff between bed efficiency and residence time. Even at the realized 55% bed efficiency, fixed-bed adsorption requires less than one-fourth the adsorbent needed for a single-stage batch adsorption process.

Curcumin histone deacetylase inhibitor and preparation method and medical application thereof

The invention relates to the fields of medicinal chemistry and biology, in particular to a curcumin histone deacetylase inhibitor. The invention also discloses a preparation method of the inhibitor and an application of the inhibitor in exerting anti-tumor activity by inhibiting histone deacetylase.

HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN

Disclosed herein are hydroxamic acid compounds. Also disclosed is a method of using the hydroxamic acid compounds for treating a condition associated with histone deacetylase 6.